Muscular exercise can cause highly pathological liver function tests in healthy men
What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. • Physical exercise can result in transient elevations of liver function tests...
Saved in:
Published in | British journal of clinical pharmacology Vol. 65; no. 2; pp. 253 - 259 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.02.2008
Blackwell Science Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | What is already known about this subject
• The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals.
• Physical exercise can result in transient elevations of liver function tests.
• There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent.
What this study adds
• Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting.
• Liver function tests are significantly increased for at least 7 days after weightlifting.
• It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies.
Aim
To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men.
Methods
Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma‐glutamyl transferase (γGT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow‐up examination 10–12 days postexercise.
Results
Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, γGT and ALP remained within the normal range.
Conclusion
The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice. |
---|---|
AbstractList | What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. • Physical exercise can result in transient elevations of liver function tests. • There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent. What this study adds • Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. • Liver function tests are significantly increased for at least 7 days after weightlifting. • It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies. Aim To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men. Methods Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma-glutamyl transferase (γGT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow-up examination 10–12 days postexercise. Results Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, γGT and ALP remained within the normal range. Conclusion The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice. The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. Physical exercise can result in transient elevations of liver function tests. There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent.WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTThe occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. Physical exercise can result in transient elevations of liver function tests. There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent.Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. Liver function tests are significantly increased for at least 7 days after weightlifting. It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies.WHAT THIS STUDY ADDSWeightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. Liver function tests are significantly increased for at least 7 days after weightlifting. It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies.To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men.AIMTo investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men.Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma-glutamyl transferase (gamma GT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow-up examination 10-12 days postexercise.METHODSFifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma-glutamyl transferase (gamma GT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow-up examination 10-12 days postexercise.Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, gamma GT and ALP remained within the normal range.RESULTSFive out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, gamma GT and ALP remained within the normal range.The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice.CONCLUSIONThe liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice. The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. Physical exercise can result in transient elevations of liver function tests. There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent. Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. Liver function tests are significantly increased for at least 7 days after weightlifting. It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies. To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men. Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma-glutamyl transferase (gamma GT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow-up examination 10-12 days postexercise. Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, gamma GT and ALP remained within the normal range. The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice. What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. • Physical exercise can result in transient elevations of liver function tests. • There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent. What this study adds • Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. • Liver function tests are significantly increased for at least 7 days after weightlifting. • It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies. Aim To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men. Methods Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma‐glutamyl transferase (γGT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow‐up examination 10–12 days postexercise. Results Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, γGT and ALP remained within the normal range. Conclusion The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice. |
Author | Pettersson, Jonas Malmqvist, Ulf Werkström, Viktoria Bengtsson, Thomas Hindorf, Ulf Persson, Paula Ekelund, Mats |
Author_xml | – sequence: 1 givenname: Jonas surname: Pettersson fullname: Pettersson, Jonas – sequence: 2 givenname: Ulf surname: Hindorf fullname: Hindorf, Ulf – sequence: 3 givenname: Paula surname: Persson fullname: Persson, Paula – sequence: 4 givenname: Thomas surname: Bengtsson fullname: Bengtsson, Thomas – sequence: 5 givenname: Ulf surname: Malmqvist fullname: Malmqvist, Ulf – sequence: 6 givenname: Viktoria surname: Werkström fullname: Werkström, Viktoria – sequence: 7 givenname: Mats surname: Ekelund fullname: Ekelund, Mats |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17764474$$D View this record in MEDLINE/PubMed https://lup.lub.lu.se/record/608027$$DView record from Swedish Publication Index oai:portal.research.lu.se:publications/cd35c777-2589-48d4-999e-b2c9bcabbf04$$DView record from Swedish Publication Index |
BookMark | eNqNUk2P0zAUtNAi9gP-AsqJW4vt2HFyAAkqvqQikIDzk-28NK7cpNjJbvvvcbalyx6Qasnykz2eGT_PNbno-g4JyRidszRer-csL-SMMy7nnFI1pzmlbL57Qq5OBxfkKu0WM8kluyTXMa4TJGeFfEYumVKFEEpckR9fx2hHr0OGOwzWRcys7tIcU9W6Vev32VYPbe_7lbPaZ97dYsiasbOD67tswDjEzHVZi9oP7T7bYPecPG20j_jiuN6QXx8__Fx8ni2_ffqyeLec2aJSbCasLo1pkiXTiKKuLM8ploZaJSte64JjRVmjrRQFr2nOpWoKUavGCFMqLU1-Q_SBN97hdjSwDW6jwx567WDbh0F7CBhRB9uCHyEiJJRPr5icR7B1Lq1SCrgsKxBlLaCqKgTDbWWsTtaoSBrL_2r4cZumOXKfSff2QJe4Nlhb7IaQbD5y_uikcy2s-lvgvGKpP4ng1ZEg9L_H1HzYuGjRe91hP0ZQlCshxaT08l-lk8Tfr0-A8gCwoY8xYPMAoTClDNYwhQmmMMGUMrhPGeweXnG6at1w39Xk2flzCN4cCO6cx_3ZwvB-8X2q8j_gtu78 |
CitedBy_id | crossref_primary_10_1016_j_smallrumres_2018_02_011 crossref_primary_10_1128_AAC_02830_14 crossref_primary_10_30699_jambs_27_121_1 crossref_primary_10_4236_crcm_2018_73016 crossref_primary_10_3390_ph17010132 crossref_primary_10_1123_ijspp_5_1_18 crossref_primary_10_1097_MPG_0b013e31818d7da2 crossref_primary_10_2478_aoas_2021_0008 crossref_primary_10_3389_fendo_2021_655756 crossref_primary_10_1016_j_jevs_2015_08_020 crossref_primary_10_2147_SAR_S495789 crossref_primary_10_1016_j_amjcard_2008_07_052 crossref_primary_10_1016_j_apunsm_2023_100404 crossref_primary_10_29219_fnr_v67_9750 crossref_primary_10_1080_1828051X_2018_1472531 crossref_primary_10_1002_cpt_1276 crossref_primary_10_5812_asjsm_109400 crossref_primary_10_54393_fbt_v3i01_36 crossref_primary_10_1186_s40798_022_00463_6 crossref_primary_10_1097_TP_0000000000004610 crossref_primary_10_1080_10495398_2020_1746322 crossref_primary_10_1371_journal_pone_0273719 crossref_primary_10_1186_s12970_016_0132_0 crossref_primary_10_61186_armaghanj_29_1_35 crossref_primary_10_3389_fmed_2022_823898 crossref_primary_10_3390_jfmk2040035 crossref_primary_10_1016_j_gcb_2008_08_007 crossref_primary_10_29252_jcbr_2_2_5 crossref_primary_10_1016_j_cbi_2022_110075 crossref_primary_10_3390_sports10100160 crossref_primary_10_4236_ojgas_2024_148029 crossref_primary_10_4055_cios20205 crossref_primary_10_1016_j_jevs_2019_07_006 crossref_primary_10_1016_j_celrep_2024_113854 crossref_primary_10_3923_jbs_2018_231_242 crossref_primary_10_1016_S1473_3099_21_00679_4 crossref_primary_10_2478_aoas_2020_0052 crossref_primary_10_1111_bjd_21840 crossref_primary_10_3390_ijms24108509 crossref_primary_10_1093_burnst_tkad007 crossref_primary_10_1093_toxsci_kfw090 crossref_primary_10_1002_hep_29802 crossref_primary_10_1016_j_jacr_2023_08_023 crossref_primary_10_5812_whb_57194 crossref_primary_10_1016_j_jevs_2015_07_009 crossref_primary_10_1080_09540105_2018_1439900 crossref_primary_10_1056_NEJMoa1108046 crossref_primary_10_1016_j_smallrumres_2019_04_003 crossref_primary_10_3399_bjgp24X737013 crossref_primary_10_1212_WNL_0b013e31820c3648 crossref_primary_10_1097_GME_0000000000000647 crossref_primary_10_15602_1983_9480_cmbs_v15n30p9_16 crossref_primary_10_23736_S0022_4707_22_13448_1 crossref_primary_10_1111_jpn_13935 crossref_primary_10_1016_j_heliyon_2023_e20427 crossref_primary_10_3357_AMHP_5862_2022 crossref_primary_10_3389_fphys_2020_01001 crossref_primary_10_1002_ccr3_546 crossref_primary_10_1093_advances_nmy115 crossref_primary_10_1088_1742_6596_1462_1_012007 crossref_primary_10_1007_s00204_021_03150_9 crossref_primary_10_1111_asj_13994 crossref_primary_10_31482_mmsl_2023_010 crossref_primary_10_1080_10495398_2019_1625783 crossref_primary_10_1177_0960327121997975 crossref_primary_10_1007_s00108_008_2231_8 crossref_primary_10_1016_j_gastrohep_2016_03_001 crossref_primary_10_1111_liv_12322 crossref_primary_10_22358_jafs_189182_2024 crossref_primary_10_32900_2312_8402_2024_131_253_261 crossref_primary_10_3390_ani12091107 crossref_primary_10_3390_metabo12121283 crossref_primary_10_1111_bjd_14207 crossref_primary_10_1016_j_jhep_2018_04_024 crossref_primary_10_1371_journal_pone_0180840 crossref_primary_10_3390_diagnostics14182014 crossref_primary_10_1016_j_livsci_2017_10_002 crossref_primary_10_1177_1535370217740853 crossref_primary_10_1016_j_smhs_2024_03_002 crossref_primary_10_54393_pbmj_v5i4_209 crossref_primary_10_3923_biotech_2020_18_22 crossref_primary_10_3748_wjg_v26_i10_1020 crossref_primary_10_1016_j_fct_2023_113890 crossref_primary_10_1016_j_scispo_2022_01_005 crossref_primary_10_3109_15376516_2013_843108 crossref_primary_10_3390_jcm9010081 crossref_primary_10_4103_ijnpnd_ijnpnd_96_23 crossref_primary_10_1016_j_smallrumres_2021_106400 crossref_primary_10_1016_j_smallrumres_2021_106522 crossref_primary_10_3390_app14167284 crossref_primary_10_1515_bhk_2018_0014 crossref_primary_10_1038_s41598_018_33008_7 crossref_primary_10_1111_1751_2980_12684 crossref_primary_10_1371_journal_pone_0239158 crossref_primary_10_1016_j_jep_2016_08_010 crossref_primary_10_1038_s41598_024_78590_1 crossref_primary_10_1055_a_1408_4793 crossref_primary_10_1371_journal_pone_0160305 crossref_primary_10_2334_josnusd_16_0367 crossref_primary_10_31196_huvfd_1281402 crossref_primary_10_3390_genes14101891 crossref_primary_10_1111_sms_14554 crossref_primary_10_3810_psm_2010_10_1815 crossref_primary_10_1039_D4FO04931D crossref_primary_10_2478_aoas_2024_0053 crossref_primary_10_3390_ani14131878 crossref_primary_10_61186_jspac_38872_2_5_50 crossref_primary_10_1039_C7FO00465F crossref_primary_10_1515_cclm_2023_0313 crossref_primary_10_1007_s12662_020_00662_x crossref_primary_10_23736_S0022_4707_21_11812_2 crossref_primary_10_29252_mlj_14_1_44 crossref_primary_10_1139_h2012_008 crossref_primary_10_1016_j_anifeedsci_2017_02_012 crossref_primary_10_1016_j_livsci_2017_08_001 crossref_primary_10_7717_peerj_10228 crossref_primary_10_1007_s12291_024_01286_w crossref_primary_10_5812_jamm_100409 crossref_primary_10_1016_j_smallrumres_2020_106249 crossref_primary_10_1038_ajg_2016_517 crossref_primary_10_1080_16546628_2017_1330098 crossref_primary_10_1089_omi_2015_0065 crossref_primary_10_3923_jas_2019_241_246 crossref_primary_10_1016_j_tice_2024_102680 crossref_primary_10_1039_D0NR01493A crossref_primary_10_1016_j_yrtph_2009_11_001 crossref_primary_10_3390_diagnostics15020179 crossref_primary_10_3390_ijerph17124375 crossref_primary_10_1038_s41684_020_0503_7 crossref_primary_10_1016_j_livsci_2020_104228 crossref_primary_10_1024_1661_8157_a003873 crossref_primary_10_1024_1661_8157_a003872 crossref_primary_10_1111_j_1365_2125_2012_04369_x crossref_primary_10_1590_S1984_82502009000200010 crossref_primary_10_1111_bcp_14736 crossref_primary_10_3389_fvets_2022_989606 crossref_primary_10_1038_s41598_023_41908_6 crossref_primary_10_5812_jcrps_105116 crossref_primary_10_1080_02640414_2014_944559 crossref_primary_10_3390_ijerph18041537 crossref_primary_10_3390_ijerph18073581 crossref_primary_10_3892_ijmm_2012_1106 crossref_primary_10_33459_cbubesbd_1250222 crossref_primary_10_1155_2021_6653266 crossref_primary_10_1007_s10735_024_10277_3 crossref_primary_10_4269_ajtmh_19_0846 crossref_primary_10_1016_S1728_869X_09_60011_3 crossref_primary_10_1097_MOG_0b013e3282f9764b crossref_primary_10_1128_AAC_01371_19 crossref_primary_10_3389_fendo_2022_1059473 crossref_primary_10_1016_j_nut_2016_01_017 crossref_primary_10_1016_j_anifeedsci_2016_04_012 crossref_primary_10_1590_s1806_92902017000800008 crossref_primary_10_1017_S0007114512005879 crossref_primary_10_3109_07420528_2015_1079215 crossref_primary_10_3390_ani10091621 crossref_primary_10_14712_23362936_2022_25 crossref_primary_10_12659_AJCR_890726 crossref_primary_10_1016_j_smallrumres_2024_107305 crossref_primary_10_1016_S1995_7645_14_60293_5 crossref_primary_10_1007_s11332_020_00723_6 crossref_primary_10_1210_er_2013_1058 crossref_primary_10_1007_s11695_009_9806_x crossref_primary_10_1111_jcpe_13556 crossref_primary_10_1371_journal_pone_0177174 crossref_primary_10_1111_liv_14774 crossref_primary_10_3390_foods11050631 crossref_primary_10_1248_bpb_b18_00504 crossref_primary_10_1542_peds_2015_2940 crossref_primary_10_1111_liv_13441 crossref_primary_10_1515_jbcpp_2017_0069 crossref_primary_10_1080_01443615_2020_1787966 crossref_primary_10_1002_cam4_4473 crossref_primary_10_1155_2018_6484610 crossref_primary_10_1002_hep4_1932 crossref_primary_10_1111_j_1365_2125_2008_03244_x crossref_primary_10_5812_jhealthscope_100409 crossref_primary_10_1016_j_fct_2022_113445 crossref_primary_10_15616_BSL_2018_24_4_411 crossref_primary_10_1016_j_anndiagpath_2024_152333 crossref_primary_10_1371_journal_pone_0240562 crossref_primary_10_1007_s42978_024_00305_9 crossref_primary_10_1007_s00431_023_04825_4 crossref_primary_10_1017_S0022029918000043 crossref_primary_10_1007_s11606_014_2766_4 crossref_primary_10_3390_gastroent15040075 crossref_primary_10_3390_ijms22136812 crossref_primary_10_1155_2019_1695874 crossref_primary_10_1097_MD_0000000000003843 crossref_primary_10_3390_ani12111432 crossref_primary_10_5352_JLS_2009_19_6_804 crossref_primary_10_1515_cclm_2018_0656 crossref_primary_10_1155_2013_275431 crossref_primary_10_1080_02701367_2022_2068792 crossref_primary_10_3390_ijms23116049 crossref_primary_10_5005_jp_journals_10018_1184 crossref_primary_10_1093_tas_txad010 crossref_primary_10_1186_1556_276X_9_261 crossref_primary_10_1016_j_foodres_2016_03_001 crossref_primary_10_3892_ijmm_2018_3644 crossref_primary_10_4103_jfmpc_jfmpc_1923_22 crossref_primary_10_1024_0300_9831_a000445 crossref_primary_10_3109_10715762_2014_928410 crossref_primary_10_3357_AMHP_6148_2023 crossref_primary_10_1016_j_fct_2013_02_015 crossref_primary_10_1021_acs_analchem_2c00041 crossref_primary_10_1519_JSC_0000000000001102 crossref_primary_10_1111_asj_13858 crossref_primary_10_14218_JCTH_2020_00005 crossref_primary_10_29252_koomesh_22_2_351 crossref_primary_10_1080_10495398_2019_1622556 crossref_primary_10_2478_v10030_008_0022_6 crossref_primary_10_3390_su12208633 crossref_primary_10_1039_C7FO00189D crossref_primary_10_7883_yoken_JJID_2024_015 crossref_primary_10_3390_nu16183061 crossref_primary_10_33206_mjss_549949 crossref_primary_10_1016_j_gastre_2016_03_011 crossref_primary_10_1016_j_psym_2015_03_002 crossref_primary_10_3389_fnut_2021_740741 crossref_primary_10_1097_MED_0b013e3283524008 crossref_primary_10_1016_j_scispo_2014_09_002 crossref_primary_10_3390_ijerph16183279 crossref_primary_10_3748_wjg_v30_i42_4576 crossref_primary_10_3390_data9010015 crossref_primary_10_2478_aoas_2020_0086 crossref_primary_10_2478_aoas_2020_0083 crossref_primary_10_1111_jdv_19925 crossref_primary_10_1093_toxsci_kfae143 crossref_primary_10_1007_s11377_009_0340_0 crossref_primary_10_1038_s41467_023_36858_6 crossref_primary_10_15407_nnn_18_03_449 crossref_primary_10_3389_fvets_2022_1048409 crossref_primary_10_1080_10495398_2020_1870485 crossref_primary_10_1016_j_jevs_2016_08_016 crossref_primary_10_3390_foods10112628 |
Cites_doi | 10.1136/bjsm.2002.002873 10.1016/S0002-9378(98)70645-3 10.1007/BF00637392 10.1007/s00134-003-1800-5 10.1016/0009-8981(77)90006-7 10.1093/clinchem/47.5.867 10.1016/0264-410X(92)90417-I 10.1111/j.1399-6576.2005.00577.x 10.1055/s-2007-972660 10.1093/clinchem/19.12.1380 10.1016/S0196-0644(94)70356-6 10.1046/j.1365-2125.2003.01969.x 10.1093/ajcp/79.6.716 10.1038/nrd1750 10.1123/ijsn.3.1.76 10.1249/01.mss.0000210192.49210.fc 10.1038/193942a0 10.1093/ndt/9.6.637 |
ContentType | Journal Article |
Copyright | 2007 The Authors 2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd 2008 |
Copyright_xml | – notice: 2007 The Authors – notice: 2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd 2008 |
CorporateAuthor | Avdelningen för klinisk kemi och farmakologi Division of Clinical Chemistry and Pharmacology Faculty of Medicine Lunds universitet Department of Laboratory Medicine Medicinska fakulteten Lund University Institutionen för laboratoriemedicin |
CorporateAuthor_xml | – name: Faculty of Medicine – name: Medicinska fakulteten – name: Division of Clinical Chemistry and Pharmacology – name: Avdelningen för klinisk kemi och farmakologi – name: Lund University – name: Institutionen för laboratoriemedicin – name: Department of Laboratory Medicine – name: Lunds universitet |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTPV AOWAS D95 |
DOI | 10.1111/j.1365-2125.2007.03001.x |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Lunds universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1365-2125 |
EndPage | 259 |
ExternalDocumentID | oai_portal_research_lu_se_publications_cd35c777_2589_48d4_999e_b2c9bcabbf04 oai_lup_lub_lu_se_cd35c777_2589_48d4_999e_b2c9bcabbf04 PMC2291230 17764474 10_1111_j_1365_2125_2007_03001_x BCP3001 |
Genre | article Journal Article Comparative Study |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S G.N GODZA GX1 H.X HF~ HGLYW HYE HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RPM RX1 SUPJJ TEORI TR2 UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7X8 5PM ADTPV AOWAS D95 |
ID | FETCH-LOGICAL-c6971-4ca8bbf316bf46d9c230e8b0c7592da62e901fac5462d03257f64d7fb4b87a5b3 |
IEDL.DBID | DR2 |
ISSN | 0306-5251 1365-2125 |
IngestDate | Fri Aug 29 03:12:28 EDT 2025 Thu Jul 03 05:24:54 EDT 2025 Thu Aug 21 14:10:28 EDT 2025 Fri Jul 11 05:12:27 EDT 2025 Mon Jul 21 06:03:34 EDT 2025 Tue Jul 01 02:29:24 EDT 2025 Thu Apr 24 23:09:08 EDT 2025 Wed Jan 22 16:22:38 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c6971-4ca8bbf316bf46d9c230e8b0c7592da62e901fac5462d03257f64d7fb4b87a5b3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/2291230 |
PMID | 17764474 |
PQID | 70274544 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | swepub_primary_oai_portal_research_lu_se_publications_cd35c777_2589_48d4_999e_b2c9bcabbf04 swepub_primary_oai_lup_lub_lu_se_cd35c777_2589_48d4_999e_b2c9bcabbf04 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2291230 proquest_miscellaneous_70274544 pubmed_primary_17764474 crossref_primary_10_1111_j_1365_2125_2007_03001_x crossref_citationtrail_10_1111_j_1365_2125_2007_03001_x wiley_primary_10_1111_j_1365_2125_2007_03001_x_BCP3001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2008 |
PublicationDateYYYYMMDD | 2008-02-01 |
PublicationDate_xml | – month: 02 year: 2008 text: February 2008 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England |
PublicationTitle | British journal of clinical pharmacology |
PublicationTitleAlternate | Br J Clin Pharmacol |
PublicationYear | 2008 |
Publisher | Blackwell Publishing Ltd Blackwell Science Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell Science Inc |
References | 1994; 9 2004; 38 1984; 65 1993; 33 2006; 38 2004; 57 1958; 12 1962; 193 1994; 23 1973; 19 1997; 18 2005; 4 2003; 29 2005; 71 1992; 10 2005; 49 1989; 58 2001; 47 1998; 178 1983; 79 1993; 3 1977; 81 Giboney PT. (e_1_2_6_2_2) 2005; 71 Koutedakis Y (e_1_2_6_10_2) 1993; 33 Loll H (e_1_2_6_4_2) 1958; 12 e_1_2_6_20_2 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_18_2 Statland BE (e_1_2_6_19_2) 1973; 19 e_1_2_6_9_2 Dajani LK (e_1_2_6_21_2) 2001; 47 e_1_2_6_3_2 e_1_2_6_5_2 e_1_2_6_12_2 Hong CZ (e_1_2_6_6_2) 1984; 65 e_1_2_6_13_2 e_1_2_6_23_2 e_1_2_6_22_2 e_1_2_6_11_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 8499940 - Int J Sport Nutr. 1993 Mar;3(1):76-86 11325890 - Clin Chem. 2001 May;47(5):867-73 15931258 - Nat Rev Drug Discov. 2005 Jun;4(6):489-99 13582699 - Arztl Forsch. 1958 Oct 10;12(10):II/85-6 12768237 - Intensive Care Med. 2003 Jul;29(7):1121-5 8107477 - J Sports Med Phys Fitness. 1993 Sep;33(3):252-7 15954972 - Acta Anaesthesiol Scand. 2005 Jul;49(6):859-64 6742992 - Arch Phys Med Rehabil. 1984 Jul;65(7):362-5 16679975 - Med Sci Sports Exerc. 2006 Apr;38(4):623-7 15155430 - Br J Sports Med. 2004 Jun;38(3):292-4 13903983 - Nature. 1962 Mar 10;193:942-4 14748819 - Br J Clin Pharmacol. 2004 Feb;57(2):199-208 9465822 - Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):161-5 589794 - Clin Chim Acta. 1977 Dec 1;81(2):145-52 15791889 - Am Fam Physician. 2005 Mar 15;71(6):1105-10 6846261 - Am J Clin Pathol. 1983 Jun;79(6):716-9 1539458 - Vaccine. 1992;10(1):39-42 9351689 - Int J Sports Med. 1997 Aug;18(6):431-7 7970089 - Nephrol Dial Transplant. 1994;9(6):637-41 18662292 - Br J Clin Pharmacol. 2008 Nov;66(5):725 4757367 - Clin Chem. 1973 Dec;19(12):1380-3 2737198 - Eur J Appl Physiol Occup Physiol. 1989;58(7):786-90 8198305 - Ann Emerg Med. 1994 Jun;23(6):1301-6 |
References_xml | – volume: 38 start-page: 623 year: 2006 end-page: 7 article-title: Serum creatine kinase and renal function measures in exertional muscle damage publication-title: Med Sci Sports Exerc – volume: 23 start-page: 1301 year: 1994 end-page: 6 article-title: Exercise‐induced rhabdomyolysis publication-title: Ann Emerg Med – volume: 38 start-page: 292 year: 2004 end-page: 4 article-title: Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department publication-title: Br J Sports Med – volume: 57 start-page: 199 year: 2004 end-page: 208 article-title: The influence of diet upon liver function tests and serum lipids in healthy male volunteers resident in a Phase I unit publication-title: Br J Clin Pharmacol – volume: 18 start-page: 431 year: 1997 end-page: 7 article-title: The effect of training status on the serum creatine kinase response, soreness and muscle function following resistance exercise publication-title: Int J Sports Med – volume: 58 start-page: 786 year: 1989 end-page: 90 article-title: Serum and urinary markers of skeletal muscle tissue damage after weight lifting exercise publication-title: Eur J Appl Physiol Occup Physiol – volume: 19 start-page: 1380 year: 1973 end-page: 3 article-title: Factors contributing to intra‐individual variation of serum constituents: 2. Effects of exercise and diet on variation of serum constituents in healthy subjects publication-title: Clin Chem – volume: 4 start-page: 489 year: 2005 end-page: 99 article-title: Idiosyncratic drug hepatotoxicity publication-title: Nat Rev Drug Dis – volume: 29 start-page: 1121 year: 2003 end-page: 5 article-title: Serum creatine kinase as a predictor of clinical course in rhabdomyolysis: a 5‐year intensive care survey publication-title: Intens Care Med – volume: 33 start-page: 252 year: 1993 end-page: 7 article-title: Serum enzyme activities in individuals with different levels of physical fitness publication-title: J Sports Med Phys Fitness – volume: 71 start-page: 1105 year: 2005 end-page: 10 article-title: Mildly elevated liver transaminase levels in the asymptomatic patient publication-title: Am Fam Physician – volume: 81 start-page: 145 year: 1977 end-page: 52 article-title: The effects of near maximum exercise on serum enzymes: the exercise profile versus the cardiac profile publication-title: Clin Chim Acta – volume: 79 start-page: 716 year: 1983 end-page: 9 article-title: Serum enzyme changes during marathon training publication-title: Am J Clin Pathol – volume: 178 start-page: 161 year: 1998 end-page: 5 article-title: Plasma gluthatione S‐transferase alpha 1‐1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy publication-title: Am J Obstet Gynecol – volume: 12 start-page: II/85 year: 1958 end-page: 6 article-title: ] publication-title: Artzl Forsch – volume: 3 start-page: 76 year: 1993 end-page: 86 article-title: Diet and exercise strategies of a world‐class bodybuilder publication-title: Int J Sport Nutr – volume: 49 start-page: 859 year: 2005 end-page: 64 article-title: Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis publication-title: Acta Anaesthesiol Scand – volume: 193 start-page: 942 year: 1962 end-page: 4 article-title: Effect of physical exercise on some enzymes in the serum publication-title: Nature – volume: 65 start-page: 362 year: 1984 end-page: 5 article-title: Metabolic effects of exhaustive training of athletes publication-title: Arch Phys Med Rehabil – volume: 10 start-page: 39 year: 1992 end-page: 42 article-title: Strenuous exercise simulating hepatic injury during vaccine trials publication-title: Vaccine – volume: 9 start-page: 637 year: 1994 end-page: 41 article-title: Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis publication-title: Nephrol Dial Transplant – volume: 47 start-page: 867 year: 2001 end-page: 73 article-title: Development of a rapid and sensitive immunofluorometric assay for gluthatione S‐transferase A publication-title: Clin Chem – ident: e_1_2_6_14_2 doi: 10.1136/bjsm.2002.002873 – ident: e_1_2_6_22_2 doi: 10.1016/S0002-9378(98)70645-3 – ident: e_1_2_6_13_2 doi: 10.1007/BF00637392 – ident: e_1_2_6_16_2 doi: 10.1007/s00134-003-1800-5 – ident: e_1_2_6_23_2 doi: 10.1016/0009-8981(77)90006-7 – volume: 33 start-page: 252 year: 1993 ident: e_1_2_6_10_2 article-title: Serum enzyme activities in individuals with different levels of physical fitness publication-title: J Sports Med Phys Fitness – volume: 47 start-page: 867 year: 2001 ident: e_1_2_6_21_2 article-title: Development of a rapid and sensitive immunofluorometric assay for gluthatione S‐transferase A publication-title: Clin Chem doi: 10.1093/clinchem/47.5.867 – volume: 71 start-page: 1105 year: 2005 ident: e_1_2_6_2_2 article-title: Mildly elevated liver transaminase levels in the asymptomatic patient publication-title: Am Fam Physician – ident: e_1_2_6_12_2 doi: 10.1016/0264-410X(92)90417-I – ident: e_1_2_6_20_2 doi: 10.1111/j.1399-6576.2005.00577.x – ident: e_1_2_6_9_2 doi: 10.1055/s-2007-972660 – volume: 12 start-page: II/85 year: 1958 ident: e_1_2_6_4_2 article-title: ] publication-title: Artzl Forsch – volume: 19 start-page: 1380 year: 1973 ident: e_1_2_6_19_2 article-title: Factors contributing to intra‐individual variation of serum constituents: 2. Effects of exercise and diet on variation of serum constituents in healthy subjects publication-title: Clin Chem doi: 10.1093/clinchem/19.12.1380 – ident: e_1_2_6_18_2 doi: 10.1016/S0196-0644(94)70356-6 – ident: e_1_2_6_3_2 doi: 10.1046/j.1365-2125.2003.01969.x – ident: e_1_2_6_7_2 doi: 10.1093/ajcp/79.6.716 – ident: e_1_2_6_11_2 doi: 10.1038/nrd1750 – volume: 65 start-page: 362 year: 1984 ident: e_1_2_6_6_2 article-title: Metabolic effects of exhaustive training of athletes publication-title: Arch Phys Med Rehabil – ident: e_1_2_6_8_2 doi: 10.1123/ijsn.3.1.76 – ident: e_1_2_6_15_2 doi: 10.1249/01.mss.0000210192.49210.fc – ident: e_1_2_6_5_2 doi: 10.1038/193942a0 – ident: e_1_2_6_17_2 doi: 10.1093/ndt/9.6.637 – reference: 7970089 - Nephrol Dial Transplant. 1994;9(6):637-41 – reference: 6846261 - Am J Clin Pathol. 1983 Jun;79(6):716-9 – reference: 8499940 - Int J Sport Nutr. 1993 Mar;3(1):76-86 – reference: 6742992 - Arch Phys Med Rehabil. 1984 Jul;65(7):362-5 – reference: 2737198 - Eur J Appl Physiol Occup Physiol. 1989;58(7):786-90 – reference: 9351689 - Int J Sports Med. 1997 Aug;18(6):431-7 – reference: 11325890 - Clin Chem. 2001 May;47(5):867-73 – reference: 14748819 - Br J Clin Pharmacol. 2004 Feb;57(2):199-208 – reference: 9465822 - Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):161-5 – reference: 8107477 - J Sports Med Phys Fitness. 1993 Sep;33(3):252-7 – reference: 8198305 - Ann Emerg Med. 1994 Jun;23(6):1301-6 – reference: 18662292 - Br J Clin Pharmacol. 2008 Nov;66(5):725 – reference: 15791889 - Am Fam Physician. 2005 Mar 15;71(6):1105-10 – reference: 15155430 - Br J Sports Med. 2004 Jun;38(3):292-4 – reference: 16679975 - Med Sci Sports Exerc. 2006 Apr;38(4):623-7 – reference: 15931258 - Nat Rev Drug Discov. 2005 Jun;4(6):489-99 – reference: 13582699 - Arztl Forsch. 1958 Oct 10;12(10):II/85-6 – reference: 13903983 - Nature. 1962 Mar 10;193:942-4 – reference: 1539458 - Vaccine. 1992;10(1):39-42 – reference: 12768237 - Intensive Care Med. 2003 Jul;29(7):1121-5 – reference: 589794 - Clin Chim Acta. 1977 Dec 1;81(2):145-52 – reference: 15954972 - Acta Anaesthesiol Scand. 2005 Jul;49(6):859-64 – reference: 4757367 - Clin Chem. 1973 Dec;19(12):1380-3 |
SSID | ssj0013165 |
Score | 2.3704395 |
Snippet | What is already known about this subject
• The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development... The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing... What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development... |
SourceID | swepub pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 253 |
SubjectTerms | Adolescent Adult Alanine Transaminase - blood Aspartate Aminotransferases - blood Basic Medicine Clinical Enzyme Tests - trends clinical trials Exercise - physiology Farmakologi och toxikologi gamma-Glutamyltransferase - blood Humans Liver - metabolism Liver - pathology liver function tests Liver Function Tests - trends Läkemedelskemi Male Medical and Health Sciences Medicin och hälsovetenskap Medicinal Chemistry Medicinska och farmaceutiska grundvetenskaper Methods in Clinical Pharmacology Middle Aged Muscle, Skeletal - metabolism Pharmacology and Toxicology physical exercise Time Factors Weight Lifting - physiology |
Title | Muscular exercise can cause highly pathological liver function tests in healthy men |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2125.2007.03001.x https://www.ncbi.nlm.nih.gov/pubmed/17764474 https://www.proquest.com/docview/70274544 https://pubmed.ncbi.nlm.nih.gov/PMC2291230 https://lup.lub.lu.se/record/608027 oai:portal.research.lu.se:publications/cd35c777-2589-48d4-999e-b2c9bcabbf04 |
Volume | 65 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swELcmnnjZ90c3Bn6YeKJV6ji-5HEgENvEVG0gob1YtuMIRAnV0kh0fz13cdKSwUM17cFSJNdWc747_845_46xTxDlkRUYneDWmA2lQlO0zkRDR_WOxuQ0PR0NnHxXx2fy63ly3uY_0V2YwA-xPHAjy2j8NRm4sVXfyJsMLdyhWybCGF3uiPAkdRA--iFWHxTGTVVJQsgYeyXjflLPoxP1d6oH8PNhFmXLNdqHuc0-dfSMXXVvGNJTrkb13I7cn7_IH_-PCJ6zpy2c5Z-D_r1gT3z5ku1OAh_2Yo-frq53VXt8l09WTNmLV-znSR3yYHlX-YnjSmOr8YmIlKcLTiWTOwfNp5RFwmkvJn3iCJPnFb8sebjNueDXvnzNzo4OTw-Oh22Vh6FTGWAA60xqbYELZAup8sxhUORTGzlIMpEbJTxClsK4RCqRRzG6mELJHAorbQomsfEbtlHelP4d44nw0sfgjfIphp15lntnwVoRGQnSFAMG3Ypq11KgUyWOqb4XCqFENUmUCnSCbiSqbwdsvBw5CzQga4zZ6ZRGo83ShxhT-pu60kBnAYmUA_Y2qNBqTgAEqIA90FOu5Q-IDbzfU15eNKzgQmSIQqIBOwxq2BsyrWfYLDZdee3yOHEAoEWSZhoFJTXGCV5b4TK0VFyNCP_Br0fmCTGhbomoLtr5ZvdOmNecXDV6vbYs9f7BhJ7e_-vAD2wzZPpQItIW25j_rv1HhJNzu42O4su37cZd3AETxGpV |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKOcCFfRm2-gA9dUaJ49jJgQN00XSZagRTqeJiYsdRK4Z0xExEw1_jr_BjeC9OZpq2hxFSDxwsRUpsJX77y_P3CHkrvdTTDKITMI1xlwsQRW0Sr2uw35GPStNiamBwKPpHfO84PF4hv5uzMA4fYp5wQ8mo9DUKOCak21JelWiBia6hCAPQub3zusJy35Y_IX6bvt_dAmK_Y2xne7TZ79YtBrpGxBKiJ5NEWmeBL3TGRRob8MhtpD0jw5iliWAW7GWWmJALlnoB8HcmeCozzXUkk1AHsO4tchsbiiNw_9YntviF4Vd9LNEnh2gv9NtlRNe-eds2XnF4r9Zt1uimbce6sow798mfZk9dQcy3XjHTPfPrEtzkf7rpD8i92mOnH5yIPSQrNn9E1ocO8rvcoKPFCbbpBl2nwwUYePmYfB4UrtSXNs2tKDAzjAKuECt6XFLsCt3YIDrGQhmK7gaKDIVIYDalpzl1B1ZL-t3mT8jRjXzwU7Kan-X2OaEhs9wG0ibCRhBZp3FqjZZaMy_hkidZh8iGhZSpUd6x2chYXYj2gIIKKYg9SKWqKKjOO8Sfz5w4pJMl5qw1XKpALeG_piS3Z8VUSUx3hJx3yDPHs4s1pQQfXMId2eLm-QMIeN6-k5-eVMDnjMXgaHkdsu34vjVlXExgaBhqapVJg9BIKRULo1jBRnEFoZBVmpkYlBFQw4M3-HLNOi7sVTXW1km93uRCEn3JxUUlSEvvpfq4OcSrF_86cY3c6Y8GB-pg93D_JbnrCpuw7uoVWZ39KOxr8J5n-k2lpSj5etMS-hfFIMe_ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIiEuvB_Lqz5AT91V4jh2cuAA3a5aSqsVtFLFxY0dR61Y0hXZiIafxl_hzzCOk92G9rBC6oGDpUiJR4nn7Yy_AXgtvNRTFLMTdI1xn3FURaUTr69tvyPfGk1jtwb29vn2IftwFB6twK_2LIzDh5hvuFnNqO21VfBpmnWVvK7QQg_dIBEGaHIH502B5a6pfmD6VrzdGSKv31A62jrY3O43HQb6mscCkyedREplgc9VxngaawzITaQ8LcKYpgmnBt1lluiQcZp6AYp3xlkqMsVUJJJQBUj3Btxk3Itt24jhJ7r4g-HXbSxtSI7JXuh3q4iufPOua7wU714u22zATbtxde0YR3fhd7ukrh7m66CcqYH--Rfa5P-55vfgThOvk3dOwe7DiskfwPrYAX5XG-RgcX6t2CDrZLyAAq8ewue90hX6kra1FUFRxlHilUWKnlTE9oRuPRCZ2DIZYoMNqzAE84BZQU5z4o6rVuSbyR_B4bV88GNYzc9y8xRISA0zgTAJNxHm1WmcGq2EUtRLmGBJ1gPRSpDUDca7bTUykRdyPeSgtBy0HUiFrDkoz3vgz2dOHc7JEnPWWiGVaJTsn6YkN2dlIYXd7AgZ68ETJ7ILmkJgBC7wjugI8_wBC3fevZOfntSw55TGGGZ5PdhyYt-ZMimnOBQOWRip0yDUQghJwyiWuFBMYiJkpKI6RlOE3PDwDb5cQcclvbJB2jpp6E0vbKEvSZzXerT0Wsr3m2N79exfJ67BrfFwJD_u7O8-h9uuqskWXb2A1dn30rzE0HmmXtU2isDxdSvoH5jPxm4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Muscular+exercise+can+cause+highly+pathological+liver+function+tests+in+healthy+men&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=Pettersson%2C+Jonas&rft.au=Hindorf%2C+Ulf&rft.au=Persson%2C+Paula&rft.au=Bengtsson%2C+Thomas&rft.date=2008-02-01&rft.issn=0306-5251&rft.eissn=1365-2125&rft.volume=65&rft.issue=2&rft.spage=253&rft.epage=259&rft_id=info:doi/10.1111%2Fj.1365-2125.2007.03001.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1365_2125_2007_03001_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon |